INIS
patients
100%
coronaries
82%
arteries
52%
muscles
45%
interventions
36%
monocytes
34%
mice
34%
assessments
33%
risks
31%
therapy
28%
diseases
27%
heart failure
25%
walls
25%
valves
24%
motion
23%
myocardial infarction
22%
elevation
22%
inflammation
20%
macrophages
19%
china
19%
kidneys
18%
heart disease
18%
surgery
17%
drugs
16%
blood
16%
angiography
16%
humans
15%
atherosclerosis
15%
doses
15%
kinases
15%
images
14%
populations
14%
evaluation
13%
values
13%
information
13%
proteins
13%
genes
13%
tissues
12%
interactions
12%
hypertension
12%
liver
12%
bypasses
12%
applications
12%
levels
11%
oxidation
11%
guidelines
11%
devices
11%
interleukins
11%
retention
10%
comparative evaluations
10%
Keyphrases
Peripheral Blood Mononuclear Cells
9%
Coagulant Activity
9%
Coagulation Factor VII
9%
Percutaneous Coronary Stenting
9%
Adverse Cardiac Events
9%
Coronary Stenting
9%
Ventricular Index
9%
Two-in-one
9%
AdipoRon
9%
Liver Oxidative Stress
9%
Hypertension Patients
9%
Monocytes
9%
Vascular Smooth muscle Cells
9%
Heart Failure
9%
Sgarbossa Criteria
9%
Late Development
9%
Total Occlusion
9%
Left Anterior Descending
9%
Stent Implantation
9%
Sirolimus-eluting Stent
9%
Coronary Artery Aneurysm
9%
Purulent Pericarditis
9%
Streptococcus Anginosus
9%
Inflammatory Cytokines
9%
Cardiac Allograft Vasculopathy
9%
Echocardiography
9%
Coronary Artery Pseudoaneurysm
9%
Spontaneous Coronary Artery
9%
Paradoxical Embolism
9%
Interatrial Shunt
9%
Eustachian Valve
9%
En Face View
9%
Three-dimensional Transthoracic Echocardiography
9%
Creatine Kinase Myocardial Band
9%
Diabetic Disease
9%
Leucocyte Types
9%
12/15-Lipoxygenase
9%
Clinical Update
9%
Essential Hypertension
9%
Wolff-Parkinson-White Syndrome
9%
Atorvastatin
9%
Severe Coronary Artery Disease
9%
Ventricular Assist Device
9%
Cluster of Differentiation 36 (CD36)
7%
Intravascular Ultrasound
6%
Angiography
6%
Vena Contracta Area
6%
Fractalkine
6%
Posterior Descending Coronary Artery
6%
Tumor Necrosis Factor-α
5%
Medicine and Dentistry
Three Dimensional Echocardiography
18%
Echocardiography
18%
Patient
11%
Percutaneous Coronary Intervention
11%
Assessment
9%
Heart Failure
9%
Coronary Stenting
9%
Major Adverse Cardiac Event
9%
Heart Left Ventricle Aneurysm
9%
Transthoracic Echocardiography
9%
Creatine Kinase MB
9%
Coronary Artery Aneurysm
9%
Streptococcus anginosus
9%
Cardiac Allograft Vasculopathy
9%
Valvular Heart Disease
9%
Vascular Smooth Muscle Cell
9%
Evaluation Study
9%
Paradoxical Embolism
9%
Macrophage
9%
Carcinoid
9%
Wolff-Parkinson-White Syndrome
9%
Diverticulum
9%
Pseudoaneurysm
9%
Coronary Artery
9%
Ventricular Assist Device
9%
Odds Ratio
8%
Accessory Pathway
7%
Angiography
6%
Intravascular Ultrasound
6%
Thorax Pain
6%
Aneurysm
5%
Diagnosis
5%
Diastolic Heart Failure
5%